<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04761029</url>
  </required_header>
  <id_info>
    <org_study_id>2011-KAEK-25</org_study_id>
    <nct_id>NCT04761029</nct_id>
  </id_info>
  <brief_title>Rhomboid Intercostal and Subserratus Plane Block</brief_title>
  <official_title>Investigation of the Efficacy of Unilateral Rhomboid Intercostal and Subserratus Plane Block Application for Postoperative Analgesia in Laparoscopic Cholecystectomy</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Bursa Yüksek İhtisas Education and Research Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Bursa Yüksek İhtisas Education and Research Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Laparoscopic surgery is frequently used today for abdominal region operations. Laparoscopy&#xD;
      has become the preferred treatment for cholecystectomy. Patients undergoing laparoscopic&#xD;
      cholecystectomy suffer from acute postoperative pain despite the multimodal analgesic&#xD;
      regimen. For this type of surgery, many different field blocks have been used for&#xD;
      postoperative analgesia.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      In this study, the analgesic efficacy of Unilateral Rhomboid intercostal and subserratus&#xD;
      block was investigated in patients who had laparoscopic cholecystectomy.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">January 1, 2018</start_date>
  <completion_date type="Actual">July 1, 2020</completion_date>
  <primary_completion_date type="Actual">July 1, 2020</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <intervention_model_description>retrospective</intervention_model_description>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>tramadol consumption</measure>
    <time_frame>Postoperative 24 hours</time_frame>
    <description>tramadol consumption</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Numeric Rating Scale rest</measure>
    <time_frame>postoperative 24 hours</time_frame>
    <description>Numeric Rating Scale was used for pain.Pain intensity was measured using Numeric Rating Scale (NRS) ranging from 0 (no pain) to 10 (worst pain imaginable).</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Numeric Rating Scale during movement</measure>
    <time_frame>Postoperative 24 hours</time_frame>
    <description>Numeric Rating Scale was used for pain.Pain intensity was measured using Numeric Rating Scale (NRS) ranging from 0 (no pain) to 10 (worst pain imaginable).</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>additional analgesic use</measure>
    <time_frame>Postoperative 24 hours</time_frame>
    <description>additional analgesic use</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>side effect profile</measure>
    <time_frame>Postoperative 24 hours</time_frame>
    <description>side effect profile (Nausea and vomiting)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>sensorial dermatomal block-level</measure>
    <time_frame>30 minutes after the block administration and at the postoperative 2nd hour</time_frame>
    <description>Dermatomal dispersion of sensorial block to the cold stimulus.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">50</enrollment>
  <condition>Cholecystectomy</condition>
  <condition>Postoperative Pain</condition>
  <condition>Nerve Block</condition>
  <arm_group>
    <arm_group_label>grup R</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Unilateral Rhomboid intercostal and subserratus block + intravenous patient-controlled analgesia</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Group P</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>intravenous patient-controlled analgesia</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>RIIS</intervention_name>
    <description>unilateral Rhomboid intercostal and subserratus block</description>
    <arm_group_label>grup R</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Tramadol</intervention_name>
    <description>intravenous patient-controlled analgesia (tramadol)</description>
    <arm_group_label>Group P</arm_group_label>
    <arm_group_label>grup R</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  American Society of Anesthesiology physical status I and II and who gave consent for&#xD;
             the blocks were included in the study&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  bleeding disorders,&#xD;
&#xD;
          -  mental incapacity,&#xD;
&#xD;
          -  known allergy to the local anesthetics,&#xD;
&#xD;
          -  body mass index ≥35 kg/m2&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>20 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Korgün Ökmen, Assoc. PhD.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Sağlık Bilimleri Üniversitesi Bursa Yüksek İhtisas Eğitim Ve Araştırma Hastanesi</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Bursa Yuksek Ihtisas Training and Research Hospital</name>
      <address>
        <city>Bursa</city>
        <zip>16110</zip>
        <country>Turkey</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Turkey</country>
  </location_countries>
  <verification_date>February 2021</verification_date>
  <study_first_submitted>February 16, 2021</study_first_submitted>
  <study_first_submitted_qc>February 16, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">February 18, 2021</study_first_posted>
  <last_update_submitted>February 16, 2021</last_update_submitted>
  <last_update_submitted_qc>February 16, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">February 18, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Bursa Yüksek İhtisas Education and Research Hospital</investigator_affiliation>
    <investigator_full_name>Korgün Ökmen</investigator_full_name>
    <investigator_title>Principal Investigator ,Assoc. PhD. M.D.</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Pain, Postoperative</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Tramadol</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

